96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
PEPTIDE FRAGMENT AND USE THEREOF
#302THIOREDOXIN 1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING THERETO
#303GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS
#304COMPOSITION FOR TREATING CANCER CONTAINING TELOMERASE-TARGETING GNRH ANTAGONIST-DERIVED PEPTIDE HS1002
#305SUBSTITUTED 4-(3-AMINOPROP-1-YL)AMINOQUINOLINE ANALOGS AS MODULATORS OF MELANOMA-ASSOCIATED ANTIGEN 11 UBIQUITIN LIGASE
#306ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASES
#307PEPTIDE LIQUID DROPLETS AND METHODS OF USING THE SAME
#308PEPTIDE AND METHOD FOR TREATING PAIN USING THE SAME
#309TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF
#310MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
#311ANTIMICROBIAL PEPTIDOMIMETICS
#312LYTIC DOMAIN FUSION CONSTRUCTS, CHECKPOINT INHIBITORS, AND METHODS OF MAKING AND USING SAME
#313COMBINATION OF PEPTIDE LINKERS FOR PROTEIN COVALENT SELF-ASSEMBLY USING SPONTANEOUS ISOPEPTIDE BOND
#314COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS
#315SELECTIVE TARGETING OF APOPTOSIS PROTEINS BY STRUCTURALLY-STABILIZED AND/OR CYSTEINE-REACTIVE NOXA PEPTIDES
#316PEPTIDES INHIBITING COVID-19
#317METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES
#318Compstatin Analogs with Increased Solubility and Improved Pharmacokinetic Properties
#319PEPTIDES AND THEIR USE IN THE TREATMENT OF INFLAMMATION
#320A4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
#321COMPOSITIONS AND METHODS FOR MODULATING GAMMA-C-CYTOKINE ACTIVITY
#322Conjugated hepcidin mimetics
#323NOVEL PEPTIDE TARGETING DENDRITIC CELLS, AND COMPOSITION FOR TREATING CANCER COMPRISING SAME
#324CARGO MOLECULE TRANSDUCTION DOMAIN RMAD1, VARIANT THEREOF, RECOMBINANT CARGO MOLECULE, AND METHOD FOR TRANSDUCING CARGO MOLECULE USING SAME
#325METHODS OF TREATING DUCHENNE MUSCULAR DYSTROPHY USING PEPTIDE-OLIGONUCLEOTIDE CONJUGATES
#326ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES
#327NICOTINIC ACETYLCHOLINE RECEPTOR PEPTIDE ANTAGONIST CONOTOXIN COMPOSITIONS AND RELATED METHODS
#328PEPTIDE AMPHIPHILE COMPOSITIONS AND METHODS OF USE THEREOF
#329Compositions for Colon Cleansing and the Treatment of Gastrointestinal Disorders
#330AGENTS FOR MANUFACTURE OF CO-ASSEMBLING PEPTIDES
#331Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy
#332THIOREDOXIN 1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING THERETO
#333NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#334BECLIN 1-TARGETED STAPLED PEPTIDE AND PHARMACEUTICAL COMPOSITION
#335BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2
#336KEAP1/NRF2 PROTEIN-LIKE POLYMERS
#337MODIFIED PEPTIDOMIMETICS AND METHODS OF USE
#338IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER
#339CELL-PENETRATING PEPTIDE VARIANT AND USE THEREOF
#340CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE
#341CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO
#342PEPTIDE-COMPOUND CYCLIZATION METHOD
#343NOVEL USE OF PEPTIDE FOR INHIBITING FUNCTIONS AND EXPRESSIONS OF MULTIPLE DISEASE BIOMARKERS
#344REGULATORY T CELL-INDUCING PEPTIDE AND COMPOSITION INCLUDING SAME FOR PREVENTING OR TREATING AUTOIMMUNE DISEASE
#345THERAPEUTIC PEPTIDES
#346MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
#347MATERIAL AND METHOD TO SCREEN PROTEASOME STIMULATORS
#348VISTA Antagonist and Methods of Use
#349PEPTIDES FOR USE IN THE TREATMENT OR PREVENTION OF MYOCARDIAL DAMAGE
#350BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF
#351BRANCHED PEPTIDES FOR ENZYMATIC ASSEMBLY AND MITOCHONDRIA DRUG DELIVERY
#352METHODS AND SORTILIN BINDING CONJUGATE COMPOUNDS FOR TARGETING CANCER STEM CELLS
#353Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#354MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF
#355PEPTIDES AND CONJUGATES THEREOF AS ACE-2 AND S1 SUBUNIT MIMICS AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV2) INFECTION
#356Activatable Membrane-Interacting Peptides and Methods of Use
#357CD70-TARGETED MICELLES ENHANCE HIF2? siRNA DELIVERY AND INHIBIT ONCOGENIC FUNCTIONS IN PATIENT-DERIVED CLEAR CELL RENAL CARCINOMA CELLS
#358ANTIBIOTIC NATURAL PRODUCT ANALOGUES
#359TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF
#360PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES
#361ANTIMICROBIAL PEPTIDOMIMETICS
#362COMBINATION OF PEPTIDE LINKERS FOR PROTEIN COVALENT SELF-ASSEMBLY USING SPONTANEOUS ISOPEPTIDE BOND
#363SELECTIVE TARGETING OF APOPTOSIS PROTEINS BY STRUCTURALLY-STABILIZED AND/OR CYSTEINE-REACTIVE NOXA PEPTIDES
#364INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS
#365OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY
#366MASP INHIBITORY COMPOUNDS AND USES THEREOF
#367Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
#368POLYPEPTIDE INHIBITORS OF LACTATE DEHYDROGENASE ACTIVITY FOR USE IN CANCER THERAPY
#369FUSION PEPTIDES CONTAINING DIMERIC ALPHA-HELICES, PEPTIDE-MOLECULARCONJUGATES CONTAINING THE SAME AND NUCLEIC ACID DELIVERY COMPOSITIONSCONTAINING THE SAME
#370STAPLED PEPTIDES AND METHODS THEREOF
#371THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#372Dosing regimens and related compositions and methods
#373TISSUE OCCLUDING AGENT COMPRISING AN IEIKIEIKIEIKI PEPTIDE
#374BINDING PEPTIDES AND USES THEREOF
#375BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS
#376EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE
#377IMMUNOMODULATORY PEPTIDE
#378SELECTIVE MENA BINDING PEPTIDES
#379EGFR TARGETING PEPTIDE CONJUGATE
#380PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#381PEPTIDES AND METHODS FOR THE TREATMENT OF DIABETES
#382Compositions and methods of treating ocular diseases
#383Anti-inflammatory peptides and composition comprising the same
#384CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE
#385NOVEL PEPTOID POLYMERS AND METHODS OF USE
#386Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders
#387MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE
#388PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#389SELF-ASSEMBLING PEPTIDES, NANOFIBERS, AND METHODS OF USE
#390ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS
#391ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS
#392VEGF-REGULATING PEPTIDES
#393SUPRAMOLECULAR FILAMENTOUS ASSEMBLIES FOR PROTEIN PURIFICATION
#394Bicyclic peptide ligands specific for MT1-MMP
#395CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF
#396Fusion protein composition(s) comprising masked type i interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
#397KHL POLYPEPTIDE, AND USE THEREOF IN PREPARATION OF TABP-EIC CELL
#398PEPTIDE COMPOSITIONS AND METHODS FOR INHIBITING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY
#399RESIN AND CHROMATOGRAPHY COLUMN THAT PURIFIES ANTIBODIES WITH PROTEASE RESISTANT SMALL PEPTIDES
#400PD-1 Peptide Inhibitors
#401IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
#402Quantum Dot-Peptide PNA-DNA Complexes as a Platform Reporter System for Multiplexed Detection in Cell-Free Transcription Translation-Based Biosensors
#403PEPTIDES FOR INCREASING DRUG DELIVERY TO CANCER
#404SWITCHING PEPTIDE AND MULTIPLEX IMMUNOASSAY METHOD USING SAME
#405PEPTIDE COMPOUNDS FOR REDUCING SIDE EFFECTS OF CB1 RECEPTOR AGONISTS
#406Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#407SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#408CD200 INHIBITORS AND METHODS OF USE THEREOF
#409PEPTIDE COMPOSITIONS AND METHODS FOR ANTI-CD3 BINDING DOMAINS
#410PEPTIDE CONJUGATES
#411ANTI-INFLAMMATORY PEPTIDE FOR PREVENTING OR TREATING ATOPIC DERMATITIS
#412COMPOSITION FOR PREVENTING OR TREATING PANCREATIC CANCER COMPRISING PEPTIDE NUCLEIC ACID COMPLEX
#413ARTIFICIAL SHORT INTERFERING PEPTIDE FOR THE PHOSPHORYLATION SUBSTRATE OF DAPK1 AND ITS PHARMACEUTICAL APPLICATIONS
#414Integrin binding peptides and uses thereof
#415MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#416COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS
#417POLYPEPTIDES INCLUDING A BETA-TRICALCIUM PHOSPHATE-BINDING SEQUENCE AND USES THEREOF
#418MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS
#419Method for conjugating antibody and physiologically active substance
#420SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF
#421Peptide Inhibitors of Human Mitochondrial Fission Protein 1 and Methods of Use
#422HEMOSTATIC ELASTIN-LIKE POLYPEPTIDES
#423PEPTIDES AND METHODS OF USE
#424IMMUNOASSAY USING CARBON NANOMATERIALS AND METHOD OF DETECTING TARGET ANTIGEN USING THE SAME
#425THERAPEUTIC MULTI-TARGETING CONSTRUCTS AND USES THEREOF
#426PEPTIDES AND USES THEREOF IN MODULATION OF AMYLOID-BETA PROTEIN DEGRADING PROTEASES
#427AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
#428BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2
#429Anti-inflammatory peptides and composition comprising the same
#430A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF
#431WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE
#432Stapled peptide and use thereof in preparation of drug for treating pancreatic cancer
#433PD-1 Peptide Inhibitors
#434CARDIAC-SPECIFIC TARGETING-PEPTIDE (CTP), COMPOSITIONS, AND USES THEREOF
#435COMPOSITIONS AND METHODS FOR TREATING DISEASES
#436RADIOACTIVE COMPLEXES OF ANTI-HER2 ANTIBODY, AND RADIOPHARMACEUTICAL
#437BRAIN PENETRATING PEPTIDES
#438CYCLIC APELIN RECEPTOR AGONISTS
#439LINEAR APELIN RECEPTOR AGONISTS
#440SCAFFOLDING PROTEIN FOR GENERATING ANTIGEN-BINDING CHIMERAL PROTEINS
#441PEPTIDES THAT BLOCK TRANSMISSION OF ORTHOTOSPOVIRUSES AND METHODS OF USING THE SAME
#442Alloferon Peptide and Method Using the Same
#443METHODS FOR TREATING AND/OR PREVENTING UNDESIRABLE SEQULAE OF NASAL TURBINOPLASTY OR FUNCTIONAL ENDOSCOPIC SINUS SURGERY
#444Compositions and method for optimized peptide vaccines using residue optimization
#445ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE
#446Inhibition of TREM receptor signaling with peptide variants
#447Polypeptide and application thereof in bone repair
#448COMPOSITION FOR IMPROVING HAIR HEALTH
#449METHOD FOR TREATMENT OF DRY EYE COMPRISNG APPLYING P55PIK INHIBITOR
#450Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
#451Method and compositions for creating magnetically aligned, bioactive scaffolds for tissue regeneration
#452PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR
#453MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof
#454Treatments for Gastrointestinal Disorders
#455NOVEL PEPTIDE, COMPOSITIONS AND METHOD FOR DELIVERY OF AGENTS INTO CELLS AND TISSUES
#456Ultra-pure agonists of guanylate cyclase C, method of making and using same
#457COMPOUNDS AND METHODS FOR TREATING TIGHT JUNCTION PERMEABILITY
#458PEPTIDES FOR TREATMENT AND PREVENTION OF NONALCOHOLIC FATTY LIVER DISEASE AND FIBROSIS
#459PEPTIDE LIGANDS FOR BINDING TO MT1-MMP
#460Sterilization of self-assembling peptides by irradiation
#461Methods and compositions for visualizing a ureter in a surgical procedure
#462NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#463PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47
#464NEW MULTI-FUNCTIONAL OLIGOPEPTIDES
#465COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#466BISPECIFIC FUSION POLYPEPTIDE COMPOUND
#467IL-7Rαγc ligand immunoglobulin fusion proteins
#468RECOMBINANTLY ENGINEERED POLYPEPTIDES CAPABLE OF RECYCLING NONCANONICAL COFACTORS
#469COMPOSITION COMPRISING REGENTIDE-012 OR REGENTIDE-013 FOR IMPROVING SKIN CONDITION
#470MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
#471Antifungal peptides, compounds including the same, and methods of use thereof
#472MELANOCYTE-REGULATING PEPTIDES
#47314-3-3 targeting peptides for cancer treatment
#474Peptide oligonucleotide conjugates
#475BIOACTIVE PEPTIDES HAVING DETRIMENTAL EFFECTS ON PEST SLUGS
#476PEPTIDES AND METHODS OF USE
#477A MINIMAL CATALYTIC DI-NICKEL PEPTIDE CAPABLE OF SUSTAINED HYDROGEN EVOLUTION AND METHODS OF USE THEREOF
#478ANTIMICROBIAL PEPTIDOMIMETICS
#479POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF
#480Anti-inflammatory peptides and composition comprising the same
#481MEANS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#482CHIMERIC POLYPEPTIDES AND USES THEREOF
#483Peptide compositions and methods of use
#484INHIBITORS OF COMPLEMENT FACTOR C3 AND THEIR MEDICAL USES
#485Immunogenic Compounds
#486Venom-Based Peptide and Application Thereof
#487COMPOSITION AND KIT FOR REMOVING LIPOPOLYSACCHARIDE
#488Bicyclic peptide ligands specific for nectin-4
#489MOLECULES TARGETING PROTEINS
#490Peptide and method for using same
#491NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#492FOREIGN SUBSTANCE INTRODUCTION CONSTRUCT AND USE THEREOF
#493GLP-1 RECEPTOR ANTAGONISTS
#494TELOMERASE POLYPEPTIDE VACCINE FOR TREATING CANCER
#495Compositions and methods for reducing ice crystal formation
#496PEPTIDES AND METHODS OF USE
#497TREATMENTS FOR GASTROINTESTINAL DISORDERS
#498PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF
#499Amino Acid Sequence Derived from Sars-Cov-2 and Use Thereof
#500RAMP TAG FOR INSULIN OVEREXPRESSION AND METHOD FOR MANUFACTURING INSULIN USING SAME
#501PEPTIDES AND FORMULATIONS FOR CANCER TREATMENT
#502IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
#503PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS
#504COMPOSITION FOR OVERCOMING RESISTANCE TO EGFR-TARGETING AGENT
#505ALBUMIN BINDING PEPTIDE CONJUGATES AND METHODS THEREOF
#506NOVEL POLYPEPTIDES WITH SKIN WHITENING ACTIVITY AND USE THEREOF
#507SYNTHESIS OF A GUANYLATE CYCLASE AGONIST BY FRAGMENTS BASED APPROACH
#508Immunotherapy against neuronal and brain tumors
#509NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#510NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#511MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#512MODULATORS OF TIGHT JUNCTION PERMEABILITY
#513Recombinant Nucleic Acid Construct Encoding Influenza Peptides and Compositions
#514ANTI-VIRAL COATING COMPOSITION, AND METHOD FOR FIXING ANTI-VIRAL FUSION PROTEIN TO SURFACES
#515NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#516POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF
#517COMPOSITIONS AND METHODS FOR MODULATING MYOSIN SUBFRAGMENT-2 COILED COIL STABILITY AND METHODS FOR USING THEM
#518NANOPARTICLE-LIKE DELIVERY SYSTEM
#519CCR8 peptide and T cells for use in immunotherapeutic treatment of various cancers
#520ACETYLCHOLINE MODULATION OF IMMUNE FUNCTION
#521BROAD-SPECTRUM ANTIVIRAL PEPTIDES
#522MULTIMERIC BICYCLIC PEPTIDE LIGANDS
#523SETD7 EPIGENETIC MODULATORS
#524MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#525PEPTIDE COMPOSTIONS AND METHODS FOR TREATING TAUOPATHIES
#526Potent peptide inhibitors of protein aggregation
#527Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis
#528COMPOSITION COMPRISING REGENTIDE-034 AND REGENTIDE-041 FOR SKIN CARE OR WRINKLE REDUCTION
#529Neutrophil-binding peptides
#530HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE
#531NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#532Anti-tumour response to modified self-epitopes
#533Compstatin analogues and their medical uses
#534Broad-spectrum polypeptide against enterovirus and application thereof
#535High-affinity peptide for tumor necrosis factor alpha and application thereof
#536IL-2RGAMMA BINDING COMPOUNDS
#537PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF
#538PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#539COMPLEXES FOR GENE DELETION AND EDITING
#540ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS
#541Method for treating non-small lung cancer with a population of activated T cells
#542PEPTIDE FOR SUPPRESSING CORONAVIRUS AND USE THEREOF
#543TROLOX-PEPTIDE CONJUGATE AND USE THEREOF
#544MOLECULAR TRANSPORT SYSTEM TO THE CENTRAL NERVOUS SYSTEM
#545PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BEHCET'S DISEASE AND RHEUMATOID ARTHRITIS, CONTAINING PEPTIDE OR MIXTURE THEREOF AS ACTIVE INGREDIENT
#546Melanocortin 1 receptor ligands and methods of use
#547Carrier peptide fragment for nucleolar localization and use thereof
#548REGENTIDE-041 AND COMPOSITION COMPRISING REGENTIDE-041 FOR IMPROVING SKIN CONDITION
#549PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#550Sterilization of self-assembling peptides by irradiation
#551Sterilization of self-assembling peptides by irradiation
#552CLEAVABLE LINKER COMPOSITIONS AND METHODS
#553Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
#554CELL-PENETRATING PEPTIDE AND USE THEREOF
#555COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL INFECTIONS
#556RAS INHIBITORY PEPTIDES AND USES THEREOF
#557METHODS OF DETERMINING GENE EDITING EFICIENCIES IN CELLS
#558MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#559RECOMBINANT PEPTIDES THAT BIND TO A TUMOUR-SPECIFIC ANTIBODY FOR BREAST CANCER AND USE
#560EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF
#561HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES
#562PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES
#563Compositions and methods for treating endometriosis
#564PEPTIDOMIMETIC MACROCYCLES
#565MULTIPLEXED DETECTION WITH ISOTOPE-CODED REPORTERS
#566PBP3 BINDING BICYCLIC PEPTIDE LIGANDS
#567Nano small peptide and its use in preparation of drugs for treating and preventing fundus vascular diseases
#568Immunomodulators
#569MOLECULES TARGETING MUTANT RAS PROTEIN
#570INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#571PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF
#572IMMUNE CHECKPOINT TIM3-TARGETING BINDING PEPTIDE AND APPLICATION THEREOF
#573Amyloid inhibitory peptides
#574CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS
#575Personalized immunotherapy against several neuronal and brain tumors
#576Nano small peptide and its use in preparation of drugs for treating and preventing fundus vascular diseases
#577ANTI-INFECTIVE BICYCLIC PEPTIDE CONJUGATES
#578NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#579ORTHOGONAL SAFETY SWITCHES TO ELIMINATE GENETICALLY ENGINEERED CELLS
#580MACROCYCLIC PEPTIDES AS POTENT INHIBITORS OF K-RAS G12D MUTANT
#581BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss
#582Antimicrobial peptides and methods of using same
#583CELL-PENETRATING COMPSTATIN ANALOGS AND USES THEREOF
#584Antimicrobial peptides and related methods
#585STRUCTURE-BASED PEPTIDE INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION
#586MODULATING GAMMA-C-CYTOKINE ACTIVITY
#587TUMOR-SPECIFIC POLYPEPTIDE SEQUENCE AND USE THEREOF
#588IDENTIFICATION OF MHC CLASS I PHOSPHO-PEPTIDE ANTIGENS FROM BREAST CANCER UTILIZING SHLA TECHNOLOGY AND COMPLEMENTARY ENRICHMENT STRATEGIES
#589METHODS AND COMPOSITIONS FOR TREATING MYC-DRIVEN CANCERS
#590METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS
#591Cationic cell penetrating peptides and the use thereof
#592NOVEL AAV3B VARIANTS THAT TARGET HUMAN HEPATOCYTES IN THE LIVER OF HUMANIZED MICE
#593α-sheet polypeptides and their use
#594TECHNOLOGIES USEFUL FOR ASSESSING PERMEABILITY
#595Peptides and other agents for treating pain and increasing pain sensitivity
#596NOVEL PEPTIDE HORMONES
#597MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY
#598METHODS TO SPECIFICALLY PROFILE PROTEASE ACTIVITY AT LYMPH NODES
#599BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17
#600PEPTIDES THAT ENHANCE NMDA RECEPTOR FUNCTION AND USE THEREOF